Page 1 | Search Results | Clinical Cancer Research | American Association for Cancer Research

1-6 of 6

Sort by

Sort Order Select

Journal Articles

Detection of Mutant Free Circulating Tumor DNA in the Plasma of Patients with Gastrointestinal Stromal Tumor Harboring Activating Mutations of CKIT or PDGFRA

Jacqueline Maier, Thoralf Lange, Irina Kerle, Katja Specht, Melanie Bruegel, Claudia Wickenhauser, Philipp Jost, Dietger Niederwieser, Christian Peschel, Justus Duyster, Nikolas von Bubnoff

Clin Cancer Res (2013) 19 (17): 4854–4867.

https://doi.org/10.1158/1078-0432.CCR-13-0765

Published: 02 September 2013

View articletitled, Detection of Mutant Free Circulating Tumor DNA in the Plasma of Patients with Gastrointestinal Stromal Tumor Harboring Activating Mutations of CKIT or PDGFRA

Includes: Supplementary data

Journal Articles

Sequential Inhibitor Therapy in CML: In Vitro Simulation Elucidates the Pattern of Resistance Mutations after Second- and Third-Line Treatment

Robert C. Bauer, Jana Sänger, Christian Peschel, Justus Duyster, Nikolas von Bubnoff

Clin Cancer Res (2013) 19 (11): 2962–2972.

https://doi.org/10.1158/1078-0432.CCR-13-0052

Published: 30 May 2013

View articletitled, Sequential Inhibitor Therapy in CML: In Vitro Simulation Elucidates the Pattern of Resistance Mutations after Second- and Third-Line Treatment

Includes: Supplementary data

Journal Articles

CBL Exon 8/9 Mutants Activate the FLT3 Pathway and Cluster in Core Binding Factor/11q Deletion Acute Myeloid Leukemia/Myelodysplastic Syndrome Subtypes

Carola Reindl, Hilmar Quentmeier, Konstantin Petropoulos, Philipp A. Greif, Tobias Benthaus, Bob Argiropoulos, Gudrun Mellert, Sridhar Vempati, Justus Duyster, Christian Buske, Stefan K. Bohlander, Keith R. Humphries, Wolfgang Hiddemann, Karsten Spiekermann

Clin Cancer Res (2009) 15 (7): 2238–2247.

https://doi.org/10.1158/1078-0432.CCR-08-1325

Published: 01 April 2009

View articletitled, CBL Exon 8/9 Mutants Activate the FLT3 Pathway and Cluster in Core Binding Factor/11q Deletion Acute Myeloid Leukemia/Myelodysplastic Syndrome Subtypes

Includes: Supplementary data

Journal Articles

Functional Analysis of Epidermal Growth Factor Receptor (EGFR) Mutations and Potential Implications for EGFR Targeted Therapy

Rama Krishna Kancha, Nikolas von Bubnoff, Christian Peschel, Justus Duyster

Clin Cancer Res (2009) 15 (2): 460–467.

https://doi.org/10.1158/1078-0432.CCR-08-1757

Published: 15 January 2009

View articletitled, Functional Analysis of Epidermal Growth Factor Receptor (EGFR) Mutations and Potential Implications for EGFR Targeted Therapy

Includes: Supplementary data

Journal Articles

Early Response Assessment Using 3′-Deoxy-3′-[¹⁸F]Fluorothymidine-Positron Emission Tomography in High-Grade Non-Hodgkin's Lymphoma

Ken Herrmann, Hinrich A. Wieder, Andreas K. Buck, Marion Schöffel, Bernd-Joachim Krause, Falko Fend, Tibor Schuster, Christian Meyer zum Büschenfelde, Hans-Jürgen Wester, Justus Duyster, Christian Peschel, Markus Schwaiger, Tobias Dechow

Clin Cancer Res (2007) 13 (12): 3552–3558.

https://doi.org/10.1158/1078-0432.CCR-06-3025

Published: 15 June 2007

View articletitled, Early Response Assessment Using 3′-Deoxy-3′-[18F]Fluorothymidine-Positron Emission Tomography in High-Grade Non-Hodgkin's Lymphoma

Journal Articles

The Tyrosine Kinase Inhibitor CGP 57148 (ST1 571) Induces Apoptosis in BCR-ABL-positive Cells by Down-Regulating BCL-X

Carsten Oetzel, Tarja Jonuleit, Alexander Götz, Heiko van der Kuip, Heike Michels, Justus Duyster, Michael Hallek, Walter E. Aulitzky

Clin Cancer Res (2000) 6 (5): 1958–1968.

Published: 01 May 2000

View articletitled, The Tyrosine Kinase Inhibitor CGP 57148 (ST1 571) Induces Apoptosis in BCR-ABL-positive Cells by Down-Regulating BCL-X

Update search

NARROW

Format

Subjects

Journal

Article Type

Issue Section

Date

Availability

Detection of Mutant Free Circulating Tumor DNA in the Plasma of Patients with Gastrointestinal Stromal Tumor Harboring Activating Mutations of CKIT or PDGFRA

Sequential Inhibitor Therapy in CML: In Vitro Simulation Elucidates the Pattern of Resistance Mutations after Second- and Third-Line Treatment

CBL Exon 8/9 Mutants Activate the FLT3 Pathway and Cluster in Core Binding Factor/11q Deletion Acute Myeloid Leukemia/Myelodysplastic Syndrome Subtypes

Functional Analysis of Epidermal Growth Factor Receptor (EGFR) Mutations and Potential Implications for EGFR Targeted Therapy

Early Response Assessment Using 3′-Deoxy-3′-[¹⁸F]Fluorothymidine-Positron Emission Tomography in High-Grade Non-Hodgkin's Lymphoma

The Tyrosine Kinase Inhibitor CGP 57148 (ST1 571) Induces Apoptosis in BCR-ABL-positive Cells by Down-Regulating BCL-X

Email alerts

AACR Journals

Update search

Detection of Mutant Free Circulating Tumor DNA in the Plasma of Patients with Gastrointestinal Stromal Tumor Harboring Activating Mutations of CKIT or PDGFRA

Sequential Inhibitor Therapy in CML: In Vitro Simulation Elucidates the Pattern of Resistance Mutations after Second- and Third-Line Treatment

CBL Exon 8/9 Mutants Activate the FLT3 Pathway and Cluster in Core Binding Factor/11q Deletion Acute Myeloid Leukemia/Myelodysplastic Syndrome Subtypes

Functional Analysis of Epidermal Growth Factor Receptor (EGFR) Mutations and Potential Implications for EGFR Targeted Therapy

Early Response Assessment Using 3′-Deoxy-3′-[18F]Fluorothymidine-Positron Emission Tomography in High-Grade Non-Hodgkin's Lymphoma

The Tyrosine Kinase Inhibitor CGP 57148 (ST1 571) Induces Apoptosis in BCR-ABL-positive Cells by Down-Regulating BCL-X

Email alerts

AACR Journals

This Feature Is Available To Subscribers Only

Early Response Assessment Using 3′-Deoxy-3′-[¹⁸F]Fluorothymidine-Positron Emission Tomography in High-Grade Non-Hodgkin's Lymphoma